Scinovex
review Open AccessTop 1% cited

Review article: the global emergence of <i>Helicobacter pylori</i> antibiotic resistance

Alimentary Pharmacology & Therapeutics · 2015 · Vol. 43(4) · pp. 514–533
Irene ThungHermineh AraminVera VavinskayaShivi GuptaJason Y. ParkSheila E. CroweMark A. Valasek

Abstract

Since the choice of empiric therapies should be predicated on accurate information regarding antibiotic resistance rates, there is a critical need for determination of current rates at a local scale, and perhaps in individual patients. Such information would not only guide selection of appropriate empiric antibiotic therapy but also inform the development of better methods to identify H. pylori antibiotic resistance at diagnosis. Patient-specific tailoring of effective antibiotic treatment strategies may lead to reduced treatment failures and less antibiotic resistance.

Helicobacter pylori-related gastroenterology studiesVeterinary medicine and infectious diseasesGastric Cancer Management and OutcomesHelicobacter pyloriAntibiotic resistanceClarithromycinMedicineAntibioticsLevofloxacinMetronidazoleDrug resistanceIntensive care medicineEmpiric therapy

MeSH terms

Anti-Infective AgentsAnti-Bacterial AgentsChinaDrug Resistance, MicrobialFemaleHumansMetronidazoleMicrobial Sensitivity TestsGlobal HealthPrevalenceHelicobacter pyloriHelicobacter InfectionsTreatment OutcomeTreatment FailureClarithromycin

Funding

  • Celgene
  • University of Texas Southwestern Medical Center
  • University of California, San Diego
Citations
730
FWCI
43.67
field-weighted impact
References
230
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.